Bevacizumab suppresses choroidal neovascularisation caused by pathological myopia

Br J Ophthalmol. 2005 Oct;89(10):1368-70.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab
  • Choroidal Neovascularization / drug therapy*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Myopia, Degenerative / complications*
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Vascular Endothelial Growth Factor A
  • Bevacizumab